ÂÜÀòÂÒÂ×

Annie Wilcoxen, PhD, has a diverse work experience spanning over several companies. Annie is currently working at bit.bio as the VP of Programme Management Office. Prior to this, they were employed as the Sr. Director of Program Management at Q32 Bio Inc. from March 2021 to April 2022. From July 2020 to February 2021, they worked as the Director of Portfolio & Program Management at Wave Life Sciences. Before that, Annie held roles at Akebia Therapeutics as the Director and Associate Director of Program & Operations Management from April 2018 to June 2020 and from April 2018 to September 2018, respectively. Annie also worked at Amgen as the Senior Product/Operations Manager/Manager from January 2014 to March 2018. Prior to their time at Amgen, Annie was employed at Eisai US as an expert in CMC Project Management & Process Development from September 2004 to December 2013. Annie began their career as a Researcher at the Institute of Chemistry, Chinese Academy of Sciences from September 1996 to August 1998.

Annie Wilcoxen, PhD, holds a BS degree in Chemistry from Nankai University. Annie further pursued their education at the University of Wisconsin-Milwaukee, where they obtained a PhD in Organic Chemistry. In addition, they have also obtained a certification in Lean Six Sigma Yellow Belt, which was awarded by Amgen.